Impax Laboratories, LLC
Amneal Pharmaceuticals is dedicated to making healthy possible through innovative medicines, accessible healthcare, and a commitment to sustainability. They operate globally, developing first-to-file and first-to-market complex medicines, and are actively involved in community and environmental initiatives. Their mission emphasizes collaboration, quality, and integrity to deliver value and improve lives.
Industries
Nr. of Employees
Very Large (1000+)
Impax Laboratories, LLC
Bridgewater, New Jersey, United States, North America
Products
Broad portfolio of generic and specialty pharmaceuticals
Approximately 280+ marketed generic and specialty products covering a range of therapeutic areas and dosage forms for retail, institutional and international markets.
Autoinjector for acute migraine treatment (FDA-approved)
An FDA-approved autoinjector product for acute migraine/cluster headache treatment delivered via subcutaneous injection; includes regulatory-approved prescribing information and boxed warning elements in labeling.
Extended-release carbidopa/levodopa capsules for Parkinson's disease (commercial launch)
Extended-release oral capsule formulation for symptomatic treatment of Parkinson’s disease delivered as a commercial specialty product.
Naloxone HCl nasal spray (over-the-counter distribution)
Nasal-spray opioid overdose reversal product distributed through retail channels and deployed in public-health outreach and donation programs to increase access.
Broad portfolio of generic and specialty pharmaceuticals
Approximately 280+ marketed generic and specialty products covering a range of therapeutic areas and dosage forms for retail, institutional and international markets.
Autoinjector for acute migraine treatment (FDA-approved)
An FDA-approved autoinjector product for acute migraine/cluster headache treatment delivered via subcutaneous injection; includes regulatory-approved prescribing information and boxed warning elements in labeling.
Extended-release carbidopa/levodopa capsules for Parkinson's disease (commercial launch)
Extended-release oral capsule formulation for symptomatic treatment of Parkinson’s disease delivered as a commercial specialty product.
Naloxone HCl nasal spray (over-the-counter distribution)
Nasal-spray opioid overdose reversal product distributed through retail channels and deployed in public-health outreach and donation programs to increase access.
Services
Large-scale production and distribution services supporting a broad portfolio of generics and specialty pharmaceuticals for retail, institutional and international customers.
Adverse event reporting, medical inquiry handling and product complaint management to support post-market safety surveillance.
Programs and card-based mechanisms to reduce patient out-of-pocket costs for eligible commercially insured patients.
Collaborative arrangements to co-develop or license products and technologies for expanded market reach.
Large-scale production and distribution services supporting a broad portfolio of generics and specialty pharmaceuticals for retail, institutional and international customers.
Adverse event reporting, medical inquiry handling and product complaint management to support post-market safety surveillance.
Programs and card-based mechanisms to reduce patient out-of-pocket costs for eligible commercially insured patients.
Collaborative arrangements to co-develop or license products and technologies for expanded market reach.
Expertise Areas
- Generic drug development
- Specialty pharmaceutical development
- Drug delivery technologies
- Biosimilars development
Key Technologies
- Topical formulation
- Transdermal patch formulation
- Transmucosal delivery
- Inhalation formulation and device delivery
News & Updates
The company published its 2024 responsible business report, highlighting sustainability and community efforts.
Showcasing the use of geothermal systems and sustainability initiatives at the Brookhaven facility.
Amneal partnered with One Tree Planted to plant 7,600 trees in 2023, emphasizing environmental sustainability.
Celebrating women’s contributions and fostering inclusion within the company.
Supplier Quality Award
Received multiple awards from Cardinal Health for quality and supply chain excellence.
HDA DIANA Award for Best Overall Generic Manufacturer
Won the award in 2010, 2013, 2016, 2017, and 2018, recognizing excellence in generic manufacturing.
The company published its 2024 responsible business report, highlighting sustainability and community efforts.
Showcasing the use of geothermal systems and sustainability initiatives at the Brookhaven facility.
Amneal partnered with One Tree Planted to plant 7,600 trees in 2023, emphasizing environmental sustainability.
Celebrating women’s contributions and fostering inclusion within the company.
Supplier Quality Award
Received multiple awards from Cardinal Health for quality and supply chain excellence.
HDA DIANA Award for Best Overall Generic Manufacturer
Won the award in 2010, 2013, 2016, 2017, and 2018, recognizing excellence in generic manufacturing.